Pharmaceuticals and biotechnology
Gespeichert in:
| Veröffentlicht in: | Wiley guide to fair value under IFRS |
|---|---|
| 1. Verfasser: | |
| Format: | UnknownFormat |
| Sprache: | eng |
| Veröffentlicht: |
2010
|
| Schlagworte: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Tag hinzufügen | Titel | Jahr | Verfasser |
|---|---|---|
| The market approach | 2010 | Hanlin, William A. |
| Assessing external risks | 2010 | Miller, Warren D. |
| Risks and rewards | 2010 | Hanlin, William A. |
| Financial statement analyses | 2010 | Costa, Martin |
| Copyrights | 2010 | Torres, Fernando |
| Intangible assets | 2010 | Sorin, Stan |
| Plant and equipment | 2010 | Körner, Evžen |
| Share-based payments | 2010 | Overstreet, Shari L. |
| Transfer pricing | 2010 | Newton, Lionel W. |
| The cost approach | 2010 | Chen, Yea-mow |
| Income approach : discounting method | 2010 | Kniest, Wolfgang |
| Excellent valuation reports | 2010 | Ruffalo, Brandi L. |
| Cost of capital | 2010 | Ballwieser, Wolfgang |
| Projecting financial statements | 2010 | Henselmann, Klaus |
| Impairment testing | 2010 | Bollmann, Frank |
| Customer relationships | 2010 | Ruffalo, Brandi L. |
| Derivatives and financial instruments | 2010 | Chan, Samuel Yat Chiu |
| Manufacturing in crisis periods | 2010 | Burckin, Emre |
| Pass-through entities | 2010 | Tindall, Laura J. |
| Patents | 2010 | Goddar, Heinz |